Global Non-Alcoholic Steatohepatitis (NASH) Drugs Market: Industry Analysis & Outlook (2017-2026)

“The Report Global Non-Alcoholic Steatohepatitis (NASH) Drugs Market: Industry Analysis & Outlook (2017-2026) provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. – MarketResearchReports.biz”

About Non-Alcoholic Steatohepatitis Market

Non-alcoholic steatohepatitis or NASH is a form of liver disease that causes inflammation and accumulation of fat tissues in the liver. It resembles alcoholic liver disease but occurs to those who drink too little or no alcohol. NASH shows no symptoms and is also known as a “Silent” liver disease. NASH can lead to cirrhosis, in which liver is permanently damaged and scarred and after a certain point, no treatment can cure it and thus lead to death.

There are two types of fatty liver disease: alcoholic fatty liver disease and non-alcoholic fatty liver disease (NAFLD). When inflammation is present with accumulation of fat in the liver then it is referred as NASH. Obesity and diabetes are most common cause of NASH disease. It is a challenge for the patient to recognize the accumulation of fat in the liver as patient experience no such symptoms until reach the advanced stage of the disease. The diagnosis of NASH includes blood tests, MRI, X-rays and liver biopsy.

Get Sample copy of this Report @ https://www.marketresearchreports.biz/sample/sample/1351219

Treatment of NASH includes managing and improving the condition of NASH from being worse and is recommended to bring changes in lifestyle and also use of off label drugs to control and manage indications related to NASH. Currently there is no approved drug in the market but is expected to enter the market in 2020. Currently, there are five potential Phase III drugs in the market including Elafibranor, Ocaliva (OCA), Cenicriviroc (CVC), Selonsertib and Aramchol.

The global NASH market is expected to show significant growth after the introduction of therapeutics drugs in 2020. Growth of market will mainly be driven by increasing patient base, rise in obese population, increasing type-2 diabetic population and increasing health expenditure. However, growth of market will also be hindered by absence of effective diagnostics, costly drugs, regulatory challenges and undefined pathogenesis.

View Report @ https://www.marketresearchreports.biz/reports/1351219/global-non-alcoholic-steatohepatitis-nash-drugs-market-research-reports

The report “Global NASH Drugs Market: Industry Analysis & Outlook (2017-2026)” analyzes the development of this market, with focus on the US and Europe region. The major trends, growth drivers as well as issues being faced by the market are discussed in detail in this report. The four major players: Genfit SA, Intercept Pharmaceuticals, Inc., Allergan Plc. (Tobira) and Gilead Sciences are being profiled along with their key financials and strategies for growth. The report contains a comprehensive analysis of the global NASH market along with the study of the regional markets.

Send An Enquiry Request @ https://www.marketresearchreports.biz/sample/enquiry/1351219

Table of Content

1. Market Overview

1.1 Nonalcoholic Steatohepatitis (NASH)

1.2 Causes & Symptoms

1.3 Diagnosis

1.4 Treatment

2. Global NASH Market

2.1 Global NASH Drugs Market Forecast by Value

2.2 Global NASH Drugs Market Forecast by Drug Class

2.3 Global NASH Off Label Drugs Market Forecast by Value

3. Global NASH Therapeutics Market

3.1 Global NASH Therapeutics Market Forecast by Value

3.2 Global NASH Therapeutics Market Forecast by Drug Type

3.3 Global NASH Therapeutics Market Forecast by Region

3.4 Global NASH Therapeutics Market by Type

3.4.1 Global Elafibranor Revenue Forecast by Value

3.4.2 Global Obeticholic Acid (OCA) Revenue Forecast by Value

3.4.3 Global Obeticholic Acid (OCA) Revenue Forecast by Region

3.4.4 Global Cenicriviroc (CVC) Revenue Forecast by Value

3.4.5 Global Cenicriviroc (CVC) Revenue Forecast by Region

3.4.6 Global Aramchol Revenue Forecast by Value

4. Regional NASH Market

4.1 The US

4.1.1 The US NASH Therapeutics Market Forecast by Value

4.2 The Europe

4.2.1 Europe NASH Therapeutics Market Forecast by Value

4.3 ROW

4.3.1 ROW NASH Therapeutics Market Forecast by Value

5. Market Dynamics

5.1 Growth Drivers

5.1.1 Rising Patient Base

5.1.2 Increasing Population with Type-2 Diabetes

5.1.3 Escalating Obese Population

5.1.4 Rising Healthcare Expenditure

5.1.5 Increasing GDP Per Capita

5.1.6 Vast Unmet Medical Need

5.2 Key Trends & Development

5.2.1 Strong Research & Development Efforts by Companies

5.2.2 Development of NASH Diagnosis Methods and Biomarkers

5.3 Challenges

5.3.1 Absence of Low-Priced and Effective Diagnostics

5.3.2 Regulatory Challenges and Undefined Pathogenesis

5.3.3 Costly NASH Therapeutics

6. Competitive Landscape

6.1 Revenue and Market Cap Comparison

6.2 Major Pipeline Products

Buy Now @ https://www.researchmoz.com/checkout?rep_id=1351219&licType=S

About us

MarketResearchReports.biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.

Contact

Mr. Nachiket

State Tower

90 Sate Street, Suite 700

Albany, NY 12207

Tel: +1-518-621-2074

Website: http://www.marketresearchreports.biz/

E: sales@marketresearchreports.biz

%d bloggers like this: